Forge Reply Announces the Release of Joe Dever’s Lone Wolf on Nintendo Switch™
Forge Reply, the video game development studio of the Reply Group, is proud to announce that its debut endeavor Joe Dever’s Lone Wolf will soon be published in digital format on Nintendo Switch™. Thanks to its versatile and flexible User Experience, the console has already left the mark in the gaming industry since its commercial launch in 2017. The Nintendo Switch™ is the latest hardware Forge Reply has been working with, in line with the identity of the studio and its constant push for innovation.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180209005020/en/
“We are happy to find a new opportunity for Joe Dever’s Lone Wolf in the Nintendo Switch™,” says Filippo Rizzante, CTO at Reply. “Even now, years after the original release, our game is being discovered by new players. The Nintendo Switch™ is a perfect fit for the unique experience created by our team, and a great opportunity to widen our reach.”
Joe Dever’s Lone Wolf has become a classic in the indie role-playing games scenario over the last years, with its mix of non-linear reading content, deep character customization and a rewarding combat system.
Watch the trailer here: https://youtu.be/QV2J3-SlDaI
Joe Dever’s Lone Wolf will be available for Nintendo Switch™ on the 16th of February 2018, published by Forge Reply.
FORGE REPLY
Forge Reply, is the Reply company specialising
in the development of games for mobile devices, smart phones and tablets
for the consumer and business markets. Forge Reply is responsible for
developing 2D and 3D titles/games for the main Application Stores, and
providing companies to introduce new ways of communicating and reporting
based on interactive methods and typical gaming features (problem
solving, engagement, teamwork) that encourage users to better reach
their clients, launch new products, refresh perceptions of their brands
or even as part of innovative courses designed to train and empower
their staff. www.forgereply.com
REPLY
Reply specialises in the design and implementation of
solutions based on new communication channels and digital media. Through
its network of specialist companies, Reply supports some of Europe’s
leading industrial groups in Telco & Media, Industry & Services, Banks &
Insurance, and Public Administration to define and develop business
models, suited to the new paradigms of Big Data, Cloud Computing,
Digital Media and the Internet of Things. Reply services include:
Consulting, System Integration and Digital Services. www.reply.com
www.lonewolfthegame.com
www.facebook.com/lonewolfthegame
www.forgereply.com
www.facebook.com/forgereply/
For press inquiries and requests related to review keys, feel free to reach out to info.forge@reply.it
© 2017 Nintendo. Nintendo Switch and Joy-Con are trademarks of Nintendo.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180209005020/en/
Contact information
MEDIA
Reply
Fabio Zappelli
f.zappelli@reply.eu
+39
02 53576.1
or
Roberta Giani
r.giani@reply.eu
+39
02 53576.1
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)14.5.2025 09:14:00 EEST | Press release
GSK plc (LSE/NYSE: GSK) and Boston Pharmaceuticals, a leading clinical stage biopharmaceutical company developing highly targeted therapies for patients with serious liver diseases, today announced that they have entered into an agreement under which GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa. Efimosfermin is a phase III-ready, potential best-in-class, investigational specialty medicine to treat and prevent progression of steatotic liver disease (SLD). Under the agreement, GSK will pay $1.2 billion upfront, with potential for additional success-based milestone payments totalling $800 million. Efimosfermin is a novel, once-monthly fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), including cirrhosis, and future development in alcohol-related liver disease (ALD), both forms of SLD. Given efimosfermin’s direct antifibrotic mechanism of action and GSK’s dat
Reply Presents “App to the Future”: A New AI-Scape Room Experience Powered by Microsoft AI and Low-Code Solutions14.5.2025 09:05:00 EEST | Press release
Reply, a global systems integrator and technology consulting firm, introduces “App to the Future” an immersive “AI-Scape Room” an immersive escape room experience powered by Microsoft Copilot, Azure AI, and Power Platform, designed to explore the full potential of AI and low-code tools in a unique and engaging way. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513072546/en/ The experience builds on Reply’s AI-Scape Room focused on Microsoft 365 Copilot, offering enhanced challenges and deeper integration of advanced AI tools to help participants better understand how these technologies can drive business transformation. Developed by WM Reply and Valorem Reply, the Reply companies specialised in digital workplace transformation and AI solutions, “App to the Future” invites participants to engage in an interactive experience where they tackle AI-powered challenges using Microsoft’s suite of tools - including Copilot, Azure
Svante Launches World's First Commercial Gigafactory for Carbon Capture & Removal Filters13.5.2025 23:50:00 EEST | Press release
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal technologies, has officially completed the commissioning of its new Centre of Excellence for Carbon Capture and Removal – Redwood manufacturing Facility (Redwood) in Burnaby, British Columbia. This milestone marks the launch of the world's first gigafactory dedicated to producing commercial-scale carbon capture and removal filters designed to trap CO2 directly from industrial emissions and the atmosphere, and with the mindset of high-volume automation and product standardization to lower the manufacturing cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513713072/en/ Claude Letourneau, President & CEO, Svante Group opens the Svante Grand Opening 2025 event, "GO25" with a speech about how to move the carbon management industry forward. This two-day event celebrates the commissioning of Svante's gigafactory in Vancouver, BC, Canada, which w
Svante and SAMSUNG E&A Sign Joint Development Agreement to Offer Digitally Enabled Skid-Mounted Modular Carbon Capture Plants13.5.2025 23:46:00 EEST | Press release
Svante Technologies Inc. (Svante) and SAMSUNG E&A announced today that they have signed a joint development agreement to jointly develop a set of standardized skid-mounted modular carbon capture plants based on Svante’s novel VeloxoTherm solid sorbent-based carbon capture filter technology, leveraging SAMSUNG E&A’s advanced digital solutions and modularization capabilities. The agreement was signed during Svante’s Grand Opening Event, which marked the commissioning of its new commercial filter manufacturing facility in Vancouver, Canada. This is the world’s first gigafactory for Svante’s filter technology, capable of producing enough filters to capture 10 million tonnes of CO2 annually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513282760/en/ Leaders of SAMSUNG E&A and Svante sign a joint development agreement at a private signing ceremony during Svante's Grand Opening Event in Burnaby, BC, Canada. The companies have
AWS and HUMAIN Announce Groundbreaking AI Zone to Accelerate AI Adoption in Saudi Arabia and Globally13.5.2025 19:09:00 EEST | Press release
Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and HUMAIN, Saudi Arabia’s newly created company responsible for driving AI innovation across the Kingdom and globally, today announced plans to invest $5 billion-plus in a strategic partnership to build a groundbreaking “AI Zone” in the Kingdom. This first-of-a-kind AI Zone will bring together multiple innovative capabilities, including dedicated AWS AI infrastructure and servers with world-class semiconductors, UltraCluster networks for faster AI training and inference, AWS services like SageMaker and Bedrock, and AI application services such as Amazon Q to advance Saudi Arabia’s mission to be a world leader in AI. AWS previously announced and is currently building an AWS infrastructure region in Saudi Arabia that will become available in 2026. Amazon is investing US$5.3 billion (approx. 19.88 billion Saudi riyal) in Saudi Arabia to develop this new region for AWS. The new AI Zone announced today is an addit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom